End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.65 TWD | +2.47% |
|
+14.99% | -29.88% |
19/06 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
19/06 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
Quotes 5-day view
End-of-day quote Taiwan S.E.24/06/2024 | 25/06/2024 | 26/06/2024 | 27/06/2024 | 28/06/2024 | |
---|---|---|---|---|---|
Last | 43.85 NT$ | 42.1 NT$ | 44 NT$ | 44.55 NT$ | 45.65 NT$ |
Volume | 565 720 | 119 066 | 244 001 | 220 160 | 239 469 |
Change | +7.48% | -3.99% | +4.51% | +1.25% | +2.47% |
Opening | 41.60 | 43.00 | 42.40 | 44.95 | 45.05 |
High | 44.85 | 43.20 | 44.30 | 45.90 | 46.00 |
Low | 41.30 | 41.60 | 42.35 | 44.40 | 45.05 |
Performance
1 day | +2.47% | ||
1 week | +14.99% | ||
Current month | +16.45% | ||
1 month | +18.42% | ||
3 months | -5.97% | ||
6 months | -30.83% | ||
Current year | -29.88% | ||
1 year | -38.89% | ||
3 years | -74.15% | ||
5 years | -79.28% |
Volumes
marketsBasic data
Highs and lows
![Extreme 41.3](/images/extremecours_fleche.png)
![Extreme 37.9](/images/extremecours_fleche.png)
![Extreme 35.05](/images/extremecours_fleche.png)
![Extreme 35.05](/images/extremecours_fleche.png)
![Extreme 35.05](/images/extremecours_fleche.png)
![Extreme 35.05](/images/extremecours_fleche.png)
![Extreme 35.05](/images/extremecours_fleche.png)
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.47% | +14.99% | -29.88% | -38.89% | 22Cr | ||
-0.80% | -0.56% | +15.20% | +35.03% | 12TCr | ||
+0.02% | +0.64% | +19.67% | +46.77% | 11TCr | ||
-1.87% | +13.91% | +18.95% | +17.92% | 2.65TCr | ||
-0.02% | -6.43% | -23.86% | -24.09% | 1.94TCr | ||
-1.88% | -2.89% | -19.03% | -31.68% | 1.62TCr | ||
-2.00% | -8.27% | -20.90% | -20.87% | 1.54TCr | ||
-0.36% | -4.62% | -46.14% | -38.48% | 1.52TCr | ||
+0.03% | +27.94% | +63.85% | +48.50% | 1.49TCr | ||
+2.50% | +2.69% | +4.49% | +45.39% | 1.35TCr | ||
+0.07% | +3.54% | +116.20% | +235.50% | 1.08TCr | ||
-4.14% | +3.78% | +20.24% | +47.91% | 856.98Cr | ||
-0.83% | +8.55% | -26.39% | -38.62% | 814.08Cr | ||
+2.65% | +37.94% | +139.15% | +266.68% | 777.24Cr | ||
+0.72% | +12.14% | +8.28% | +54.75% | 776.52Cr | ||
+0.96% | -1.90% | -3.56% | +25.16% | 737.89Cr | ||
Average | -0.16% | +6.02% | +14.77% | +39.44% | ||
Weighted average by Cap. | -0.46% | +2.90% | +15.06% | +36.39% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -29.88% | ||
2023 | -38.13% | ||
2022 | -39.59% | ||
2021 | +55.35% | ||
2020 | -16.42% | ||
2019 | -28.40% | ||
2018 | -35.50% | ||
2017 | -37.44% | ||
2016 | -35.73% | ||
2015 | +86.82% |
- Stock Market
- Equities
- 6541 Stock
- Quotes Tanvex BioPharma, Inc.